SUN-708 - Type 2 Diabetes Mellitus, Central Obesity and Low HDL Are Independent and Additive Risk Predictors of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with F2-F3 Fibrosis; A Large Liver Biopsy Based Study

Abstract Poster Presenter(s)

• 

  Claudia S. Tamayo-Torres, MD

  Postdoctoral Research Fellow
  BETH ISRAEL DEACONESS MEDICAL CENTER
  Brighton, MA, United States

Co-Author(s)

• 

  Konstantinos Stefanakis, MD

  Beth Israel Deaconess Medical Center, Harvard Medical School
  Neo Psychiko, GREECE
• AR

  Arantxa Ramirez Cisneros, MD

  Beth Israel Deaconess Medical Center, Harvard Medical School
  Boston, United States
• VG

  Valeria Gutierrez de Pineres, MD

  Beth Israel Deaconess Medical Center, Harvard Medical School
  Boston, United States
• GM

  Geltrude Mingrone, MD

  Università Cattolica del Sacro Cuore
  Rome, Italy
• JG

  Jacob George, MD

  3Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney
  New South Wales, Australia

Senior Author/Primary Investigator(s)

• 

  Christos Mantzoros, MD,DSC

  Harvard University
  Watertown, MA, United States

Co-Author(s)

• 

  Christos Mantzoros, MD,DSC

  Harvard University
  Watertown, MA, United States